NO964189D0 - Smertestillende og anti-inflammatorisk middel samt fremgangsmåte ved fremstilling derav - Google Patents

Smertestillende og anti-inflammatorisk middel samt fremgangsmåte ved fremstilling derav

Info

Publication number
NO964189D0
NO964189D0 NO964189A NO964189A NO964189D0 NO 964189 D0 NO964189 D0 NO 964189D0 NO 964189 A NO964189 A NO 964189A NO 964189 A NO964189 A NO 964189A NO 964189 D0 NO964189 D0 NO 964189D0
Authority
NO
Norway
Prior art keywords
painkiller
preparation
inflammatory agent
inflammatory
agent
Prior art date
Application number
NO964189A
Other languages
English (en)
Other versions
NO303619B1 (no
NO964189L (no
Inventor
Amarjit Singh
Rasjeh Jain
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN2048DE1995 external-priority patent/IN186558B/en
Priority to HU9601442A priority Critical patent/HUP9601442A3/hu
Priority to US08/662,477 priority patent/US5716609A/en
Priority to US08/662,704 priority patent/US5688829A/en
Priority to EP96304461A priority patent/EP0812591B1/en
Priority to NZ299481A priority patent/NZ299481A/en
Priority to AU67993/96A priority patent/AU693720B2/en
Priority to NO964189A priority patent/NO303619B1/no
Publication of NO964189D0 publication Critical patent/NO964189D0/no
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Priority to CA002188703A priority patent/CA2188703C/en
Priority to CZ963166A priority patent/CZ316696A3/cs
Priority to JP8290585A priority patent/JP2875988B2/ja
Publication of NO964189L publication Critical patent/NO964189L/no
Publication of NO303619B1 publication Critical patent/NO303619B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
NO964189A 1995-07-25 1996-10-03 Smertestillende og anti-inflammatorisk middel inneholdende nimesulid samt fremgangsmÕte ved fremstilling derav NO303619B1 (no)

Priority Applications (10)

Application Number Priority Date Filing Date Title
HU9601442A HUP9601442A3 (en) 1995-07-25 1996-05-29 Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
US08/662,477 US5716609A (en) 1995-07-25 1996-06-13 Therapeutic anti-inflammatory and analgesic composition containing nimesulide for use transdermally and a process for the manufacture thereof
US08/662,704 US5688829A (en) 1995-07-25 1996-06-13 Therapeutic injectable analgesic composition containing nimesulide and a process for the manufacture thereof
EP96304461A EP0812591B1 (en) 1995-07-25 1996-06-14 Injectable compositions containing Nimesulide
NZ299481A NZ299481A (en) 1995-07-25 1996-10-01 Pharmaceutical composition comprising nimesulide (4-nitro, 2-phenoxyphenylmethanesulphonamide)
AU67993/96A AU693720B2 (en) 1995-07-25 1996-10-02 Novel therapeutic injectable analgesic pharmaceutical composition containing Nimesulide 4-Nitro,2 Phenoxyphenyl Methane Sulphonamide for intramuscular administration
NO964189A NO303619B1 (no) 1995-07-25 1996-10-03 Smertestillende og anti-inflammatorisk middel inneholdende nimesulid samt fremgangsmÕte ved fremstilling derav
CA002188703A CA2188703C (en) 1995-07-25 1996-10-24 Therapeutic injectable analgesic pharmaceutical composition containing nimesulide 4-nitro, 2-phenoxyphenyl methane sulphonamide for intramuscular administration
CZ963166A CZ316696A3 (cs) 1995-07-25 1996-10-29 Nový injektovatelný analgetický farmaceutický prostředek obsahující nimesulid N-(4-nitro, 2-fenoxyfenyl)methansulfonamid pro nitrosvalové podávání a způsob jeho přípravy
JP8290585A JP2875988B2 (ja) 1995-07-25 1996-10-31 ４−ニトロ−２−フェノキシフェニルメタンスルホンアミドであるニメスリドを含む、新規な筋肉内投与用の注射可能な鎮痛薬剤組成物

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
IN1389DE1995 1995-07-25
IN2047DE1995 1995-11-08
IN2046DE1995 1995-11-08
IN2048DE1995 IN186558B (no) 1995-07-25 1995-11-08
EP96304461A EP0812591B1 (en) 1995-07-25 1996-06-14 Injectable compositions containing Nimesulide
NZ299481A NZ299481A (en) 1995-07-25 1996-10-01 Pharmaceutical composition comprising nimesulide (4-nitro, 2-phenoxyphenylmethanesulphonamide)
AU67993/96A AU693720B2 (en) 1995-07-25 1996-10-02 Novel therapeutic injectable analgesic pharmaceutical composition containing Nimesulide 4-Nitro,2 Phenoxyphenyl Methane Sulphonamide for intramuscular administration
NO964189A NO303619B1 (no) 1995-07-25 1996-10-03 Smertestillende og anti-inflammatorisk middel inneholdende nimesulid samt fremgangsmÕte ved fremstilling derav
CA002188703A CA2188703C (en) 1995-07-25 1996-10-24 Therapeutic injectable analgesic pharmaceutical composition containing nimesulide 4-nitro, 2-phenoxyphenyl methane sulphonamide for intramuscular administration
CZ963166A CZ316696A3 (cs) 1995-07-25 1996-10-29 Nový injektovatelný analgetický farmaceutický prostředek obsahující nimesulid N-(4-nitro, 2-fenoxyfenyl)methansulfonamid pro nitrosvalové podávání a způsob jeho přípravy
JP8290585A JP2875988B2 (ja) 1995-07-25 1996-10-31 ４−ニトロ−２−フェノキシフェニルメタンスルホンアミドであるニメスリドを含む、新規な筋肉内投与用の注射可能な鎮痛薬剤組成物

Publications (3)

Publication Number Publication Date
NO964189D0 true NO964189D0 (no) 1996-10-03
NO964189L NO964189L (no) 1998-04-06
NO303619B1 NO303619B1 (no) 1998-08-10

Family

ID=27581364

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964189A NO303619B1 (no) 1995-07-25 1996-10-03 Smertestillende og anti-inflammatorisk middel inneholdende nimesulid samt fremgangsmÕte ved fremstilling derav

Country Status (9)

Country Link
US (2) US5688829A (no)
EP (1) EP0812591B1 (no)
JP (1) JP2875988B2 (no)
AU (1) AU693720B2 (no)
CA (1) CA2188703C (no)
CZ (1) CZ316696A3 (no)
HU (1) HUP9601442A3 (no)
NO (1) NO303619B1 (no)
NZ (1) NZ299481A (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291278B1 (it) * 1996-07-05 1999-01-07 Errekappa Euroterapici S P A Preparazione farmaceutica a base di nimesulide per uso topico
IT1289972B1 (it) * 1997-02-25 1998-10-19 Helsinn Healthcare Sa Formulazioni topiche di nimesulide in forma di sistemi a cristalli liquidi
IT1289973B1 (it) 1997-02-25 1998-10-19 Helsinn Healthcare Sa Sistemi gelificati di nimesulide per uso topico
IT1291895B1 (it) * 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
US6214318B1 (en) 1997-10-02 2001-04-10 Oms Holdings Llc Aerosol ointment compositions for topical use
IN188720B (no) * 1997-11-06 2002-11-02 Panacea Biotec Ltd
AU718356B2 (en) * 1998-01-12 2000-04-13 Panacea Biotec Limited A parenteral water-miscible non-intensely coloured injectable composition of non-steroidal anit-inflammatory drugs
IN187306B (no) * 1998-01-12 2002-03-23 Panacea Biotec Ltd
GB2340751B (en) 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
ES2232434T3 (es) 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
AU1888900A (en) * 1999-05-31 2000-12-18 Shashikant Prabhudas Kurani A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide
AU5325000A (en) 1999-06-05 2000-12-28 David Houze Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use
AU3104301A (en) 2000-01-20 2001-07-31 Noven Pharmaceuticals, Inc. Compositions and methods to effect the release profile in the transdermal administration of active agents
GB0002336D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
DE10125883A1 (de) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
WO2005044227A1 (en) * 2003-11-05 2005-05-19 Glenmark Pharmaceuticals Limited Topical pharmaceutical compositions
CA2649620A1 (en) * 2006-04-24 2007-11-01 Panacea Biotec Ltd. Novel low dose pharmaceutical compositions comprising nimesulide, preparation and use thereof
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
EA023000B1 (ru) * 2012-10-25 2016-04-29 Закрытое Акционерное Общество "Фармфирма "Сотекс" Наружное средство для лечения болезней суставов и мягких тканей
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840597A (en) * 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
IT1248475B (it) * 1990-05-22 1995-01-19 Angeli Inst Spa Composti di inclusione di nimesulide con ciclodestrine
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
IT1251838B (it) * 1991-09-20 1995-05-26 Lpb Ist Farm Uso della nimesulide nel trattamento della cataratta
HU210922B (en) * 1993-05-24 1995-09-28 Europharmaceuticals Sa Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
BE1008307A3 (fr) * 1994-06-16 1996-04-02 Europharmaceuticals Sa Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation.

Also Published As

Publication number Publication date
AU6799396A (en) 1998-04-09
CA2188703A1 (en) 1998-04-24
CZ316696A3 (cs) 1998-05-13
US5716609A (en) 1998-02-10
EP0812591A1 (en) 1997-12-17
US5688829A (en) 1997-11-18
NZ299481A (en) 1997-09-22
JPH10130143A (ja) 1998-05-19
EP0812591B1 (en) 2003-09-10
CA2188703C (en) 2001-04-24
AU693720B2 (en) 1998-07-02
JP2875988B2 (ja) 1999-03-31
HUP9601442A3 (en) 1999-03-29
NO303619B1 (no) 1998-08-10
NO964189L (no) 1998-04-06
HU9601442D0 (en) 1996-07-29
HUP9601442A2 (hu) 1998-04-28

Similar Documents

Publication Publication Date Title
NO964189D0 (no) Smertestillende og anti-inflammatorisk middel samt fremgangsmåte ved fremstilling derav
NO963725D0 (no) System og fremgangsmåte ved transaksjonsprosesser
NO940825D0 (no) 2-Debenzoyl-2-acyltaxolderivater og fremgangsmåter ved fremstilling derav
BR9407799A (pt) Composição de matéria método de tratamento e composição farmaceutica
NO981108L (no) Freseapparat og fremgangsmÕte ved fresing
FI941787A0 (fi) Sähkökirurginen prosessori ja menetelmä sen käyttämiseksi
NO984947D0 (no) Avisingsmiddel og fremgangsmÕte ved anvendelse av dette
NO961368L (no) Anordning og fremgangsmåte ved telekommunikasjonssystem
BR9408463A (pt) Novos derivados de ginkgolide e processo para sua preparação
PL315635A1 (en) Method of solubilising hardly pharmaceutically active substances
BR9708270A (pt) Titánio ou liga de titánio e método de tratamento de superfície do mesmo
DK0702344T3 (da) Etiketkontinuum og fremgangsmåde til fremstilling deraf
NO980257D0 (no) Forankringsinnretning, og fremgangsmåte ved forankring
FI103463B1 (fi) Tietokone ja menetelmä tietokoneen käyttämiseksi
NO964190D0 (no) Terapeutisk smertestillende middel samt fremgangsmåte ved fremstilling derav
NO932282L (no) Oljeaktig preparat og fremgangsmaate for fremstilling av dette
KR970702939A (ko) 스패터링용 티타늄 타게트 및 그의 제조 방법(Titanium target for spattering and method of manufacturing same)
NO952978D0 (no) System og fremgangsmåte ved komplettering av anrop
AU1275097A (en) Lns-based computer processor and method of use thereof
AU2845897A (en) Photosensitive elements and their process of use
NO990018D0 (no) Belegg og fremgangsmÕte for fremstilling derav
UA10998C2 (uk) Спосіб поліфакторhої лікувальhої дії та ковдра для поліфакторhої лікувальhої дії
NO20000357L (no) Lotterisystem og fremgangsmÕte ved samme
BR9602729A (pt) Oxafosforina e processo para sua preparação
NL1006938A1 (nl) Middel met therapeutisch effect en werkwijze om zulk middel te vervaardigen.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2003

RE Reestablishment of rights (par. 72 patents act)
MM1K Lapsed by not paying the annual fees